Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Gerresheimer AG
  6. News
  7. Summary
    GXI   DE000A0LD6E6

GERRESHEIMER AG

(GXI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Gerresheimer AG and Midas Pharma Announces Strategic Partnership

11/08/2021 | 04:00am EST

Gerresheimer acquired the IP of a new generation cartridge based autoinjector from Midas Pharma. This is the start of a strategic partnership. The joint project comprises the development and marketing of the new generation autoinjector. The go-to-market approach for the autoinjector combines the complementary strengths of both companies - Gerresheimer as a solution provider for medical devices and primary packaging solutions and Midas Pharma as experienced facilitator for global pharma projects and provider of products and services along the pharmaceutical value chain. The two companies will offer biotech and pharma customers a one-stop-shop around the autoinjector solution: Starting with the selection and delivery for the best solution of a medical device and associated primary packaging plus sourcing of the active pharmaceutical ingredients, through the entire development (technical, pharmaceutical and clinical) and registration. It also includes commercial manufacturing and supply of the ready filled, sterilized and assembled drug-device-combination, supported by a full range of complementary services e.g. quality, technical and analytical, regulatory, IP or project management.


ę S&P Capital IQ 2021
All news about GERRESHEIMER AG
01/27GERRESHEIMER AG : The leading supplier of injection vials Gerresheimer expands production ..
EQ
01/27Gerresheimer Expands Production in Wertheim
CI
01/27GERRESHEIMER : The leading supplier of injection vials Gerresheimer expands production in ..
PU
01/25GERRESHEIMER AG : JP Morgan sticks Neutral
MD
01/04GERRESHEIMER AG : JP Morgan reiterates its Neutral rating
MD
2021GERRESHEIMER : enters into agreement with major American biotech to develop an innovative ..
PU
2021GERRESHEIMER AG : Gerresheimer enters into agreement with major American biotech to develo..
EQ
2021Gerresheimer Enters into an Important Agreement Involving Its Advanced Technologies Div..
CI
2021GERRESHEIMER : OJESH Pro Regeneration – Opal glass packaging by Gerresheimer underli..
PU
2021GERRESHEIMER : Ueli Utzinger appointed new Group Senior Director Communication & Marketing..
PU
More news
Analyst Recommendations on GERRESHEIMER AG
More recommendations
Financials
Sales 2021 1 493 M 1 664 M 1 664 M
Net income 2021 101 M 112 M 112 M
Net Debt 2021 979 M 1 092 M 1 092 M
P/E ratio 2021 24,6x
Yield 2021 1,67%
Capitalization 2 481 M 2 769 M 2 765 M
EV / Sales 2021 2,32x
EV / Sales 2022 2,13x
Nbr of Employees 10 175
Free-Float 100%
Chart GERRESHEIMER AG
Duration : Period :
Gerresheimer AG Technical Analysis Chart | GXI | DE000A0LD6E6 | MarketScreener
Technical analysis trends GERRESHEIMER AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Last Close Price 79,00 €
Average target price 103,03 €
Spread / Average Target 30,4%
EPS Revisions
Managers and Directors
Dietmar Siemssen Chief Executive Officer
Bernd Metzner Chief Financial Officer
Axel Herberg Chairman-Supervisory Board
Theodor Stuth Member-Supervisory Board
Udo Johannes Vetter Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
GERRESHEIMER AG-6.73%2 749
ABBOTT LABORATORIES-14.42%206 551
MEDTRONIC PLC-0.26%138 731
BECTON, DICKINSON AND COMPANY0.96%71 600
HOYA CORPORATION-18.59%44 518
BAXTER INTERNATIONAL INC.-1.41%42 374